Clinical trials
Pain trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 3 |
| The Second Affiliated Hospital of Chongqing Medical University | 3 |
| Guangzhou General Hospital of Guangzhou Military Command | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Peking Union Medical College Hospital | 2 |
| Sun Yat-sen University | 2 |
| Tianjin Medical University General Hospital | 2 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2 |
| Aier School of Ophthalmology, Central South University | 1 |
| Beijing Pins Medical Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pain | 51 |
| Postoperative Pain | 5 |
| Agnosia | 3 |
| Carcinoma, Hepatocellular | 2 |
| Neurologic Manifestations | 2 |
| Sleep Initiation and Maintenance Disorders | 2 |
| Acute Kidney Injury | 1 |
| Anxiety Disorders | 1 |
| Back Pain | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.